Please login to the form below

Not currently logged in
Email:
Password:

US Biomedical Advanced Research and Development Authority

This page shows the latest US Biomedical Advanced Research and Development Authority news and features for those working in and with pharma, biotech and healthcare.

FDA briefing document backs J&J’s one-dose COVID-19 vaccine

FDA briefing document backs J&J’s one-dose COVID-19 vaccine

In the US, the efficacy rate increased slightly to 72%, while in Latin America and South Africa the vaccine was 66% and 57% effective, respectively. ... Under the terms of the deal, the US Biomedical Advanced Research and Development Authority (BARDA)

Latest news

More from news
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest Intelligence

  • Rethinking our approach to infectious disease preparedness Rethinking our approach to infectious disease preparedness

    So we need long-term strategic investment so that we have therapies and vaccines under development – and the infrastructure to support them, from governments and the private sector – in the vital ... Achaogen and Aradigm filed for bankruptcy in 2019,

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The phase 1 study, which is being conducted by the US National Institutes of Health (NIH) at Kaiser Permanente Washington Health Research Institute in Seattle, aims to recruit 45 healthy men ... That includes an agreement with the US Biomedical Advanced

  • Deal Watch June 2016 Deal Watch June 2016

    One of the companies developing pathogen reduction systems for donated blood, Cerus Corporation, signed an agreement in June worth up to $180m with the US Biomedical Advanced Research and Development Authority ... Includes rights to sublicense outside

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...